Study on release pattern and potency status of ketoprofen solid dosage forms available in the pharma-market of Bangladesh

Journal of Pharmacology and Toxicology

Volumn 4, Issue 5, 2009, Pages 205-212

  Ali, M E ^a   Salam, M A ^b   Asad, M A ^b   Saifuzzaman, M ^b  

^a Gaco Pharmaceuticals and Research Laboratory   (Bangladesh)

^b KHULNA UNIVERSITY   (Bangladesh)

Author keywords

Disintegration test; Dissolution test; Enteric coated tablet; Potency estimation; Sustained release capsule

Indexed keywords

BUFFER; KETOPROFEN;

ARTICLE; BANGLADESH; COMPLIANCE (PHYSICAL); DISSOLUTION; DRUG CAPSULE; DRUG DOSAGE FORM; DRUG POTENCY; DRUG RELEASE; ENTERIC COATED TABLET; PH; SUSTAINED DRUG RELEASE; ULTRAVIOLET SPECTROSCOPY;

EID: 75649140254     PISSN: 1816496X     EISSN: None     Source Type: Journal    
DOI: 10.3923/jpt.2009.205.212     Document Type: Article

References (25)

1. Bethesda, M., 1996. Ketoprofen-American Hospital Formulary Services: Drug Inflammation. American Society of Health-System Pharmacists Inc., USA., pp: 1416-1422.
2. Bi, Y., H. Sunada, Y. Yonezawa, K. Danjo, A. Otsuka and K. Iida, 1996. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem. Pharm. Bull., 44: 2121-2127.
3. Bi, Y., Y. Yonezawa and H. Sunada, 1999. Rapidly disintegrating tablets prepared by the wet compression method: Mechanism and optimization. J. Pharmaceutics Sci., 88: 1004-1010.
4. Carlson, J.A., H.J. Mann and D.M. Canafax, 1983. Effect of pH on disintegration and dissolution of ketoconazole tablets. Am. J. Health-Syst. Pharmacists, 40: 1334-1336.
5. Chambliss, W.G., D.A. Chambliss, R.W. Cleary, A.B. Jones, E.C. Harland and A.H. Kibbe, 1984. Development and evaluation of enteric coated penicillamine tablets. J. Pharm. Sci., 73: 1215-1219.
6. Csoka, I., E. Csanyi, G. Zapantis, E. Nagy and A. Feher-Kiss et al., 2005. In vitro and in vivo percutaneous absorption of topical dosage forms: Case studies. Int. J. Pharmaceutics, 291: 11-19.
7. Elworthy, P. and F. Lipscomb, 1968. Effect of some non-ionic surfactants and a polyoxyethylene glycol on the dissolution rate of griseofulvin. J. Pharm. Pharmcol., 20: 923-933.
8. Fares, H.M. and J.L. Zatz, 1995. Measurement of drug release from topical gels using two types of apparatus. Pharmaceutical Technol., 19: 52-58.
9. Hardman, G. and L.E. Limbird, 1996. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th Edn., McGraw-Hill Companies, New York, pp: 633-634.
10. He, Y.Y., D.C. Ramirez, D.C. Detweiler, R.P. Mason and C.F. Chignell, 2003. UVA ketoprofen-induced hemoglobin radicals detected by immuno-spin trapping. Photochem. Photobiol., 77: 585-591.
11. Insel, P., 1996. Analgesic-antipyretic and Anti-inflammatory Agents and Drugs Employed in the Treatment of Gout. In: Goodman and Gilman's: The Pharmacological Basis of Therapeutics, Hardman, J., L. Limbird and P.B. Molinoff (Eds.). 9th Edn., McGraw-Hill Inc., New York, pp: 617-658.
12. Lachman, A.H. and L.J. Liberman, 1991. The Theory and practices of Industrial Pharmacy. Lea and Febiger, Philadelphia, USA., pp: 374-377.
13. Liebenberg, W., E. Engelbrecht, A. Wessels, B. Devarakonda, W. Yang and M.M.D. Villiers, 2004. A comparative study of the release of active ingredients from semisolid cosmeceuticals measured with Franz, enhancer or flow-through cell diffusion apparatus. J. Food Drug Anal., 12: 19-28.
14. Lippold, B.C. and A. Ohm, 1986. Correlation between wettability and dissolution rate of pharmaceutical powders. Int. J. Pharm., 28: 67-74.
15. Miyagawa, Y., T. Okabe, Y. Yamaguchi, M. Miyajima, H. Sato and H. Sunada, 1996. Controlled-release of diclofenac sodium from wax matrix granule. Int. J. Pharmaceut., 138: 215-224.
16. Mura, P., J.R. Moyano, M.L. González-Rodríguez, A.M. Rabasco-Alvaréz, M. Cirri and F. Maestrelli, 2005. Characterization and dissolution properties of ketoprofen in binary and ternary solid dispersions with polyethylene glycol and surfactants. Drug Dev. Ind. Pharmacy, 31: 425-434.
17. Olander, D.R., 1960. Simultaneous mass transfer and equilibrium chemical reaction. AIChE J., 6: 233-239.
18. Sakr, A., A. Aboutaleb, A. Kassem and S. Khidr, 1980. Study on the dissolution and bioavailability of directly compressed salicylamide tablets. Pharm. Ind., 42: 412-415.
19. Samaligy, M. and P. Szantmiklosi, 1978. Effect of surfactants on the release of a hydrophobic liquid drug from its tablet form. Pharm. Ind., 40: 274-277.
20. Schott, H., L.C. Kwa and S. Feldman, 1982. The role of surfactants in the release of very slightly soluble drugs fiom tablets. J. Pharm. Sci., 71: 1038-1045.
21. Shah, V.P., 1993. Practical Considerations in Developing a Quality Control (in vitro release) Procedure for Topical Drug Products. In: Topical Drug Bioavailability, Bioequivalence and Penetration, Maibach, H.I. (Ed.). Plenum Press, New York, USA., pp: 107-115.
22. Shah, V.P., J.S. Elkins and R.L. Williams, 1999. Role on in vitro Release Measurement in Semisolid Dosage Forms. In: Percutaneous Absorption-Drugs, Cosmetics, Mechanisms and Methodology, Bronaugh, R.L. and H.I. Maibach (Eds.). Marcel Dekker Inc., New York, USA., pp: 555-570.
23. Shargel, L. and B.C. Andrew, 1941. Modified-release Drug Products and Targeted Drug Delivery System: Applied Biopharmaceutics and Pharmacokinetics. 3rd Edn., Appleton and Lange, Connecticut, USA., pp: 225-264.
24. Tripathi, K.D., 2000. Essentials of Medical Pharmacology. 4th Edn., Jaypee Brothers Medical Publishers (P) Ltd., New Delhi, India, pp: 459-560.
25. Zatz, J.L., 1995. Drug release from semisolids: Effect of membrane permeability on sensitivity to product parameters. Pharmaceutical Res., 12: 787-789.